Trials / Conditions / Chemotherapy Induced Anemia

Chemotherapy Induced Anemia

9 registered clinical trials studyying Chemotherapy Induced Anemia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy NCT06075030	Kind Pharmaceuticals LLC	Phase 2
Not Yet Recruiting	Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies NCT06854276	Shenyang Sunshine Pharmaceutical Co., LTD.	Phase 2
Completed	A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receivin NCT05301517	Kyntra Bio	Phase 3
Completed	Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia NCT04076943	Kyntra Bio	Phase 2
Completed	Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology NCT02158169	Hospira, now a wholly owned subsidiary of Pfizer	—
Terminated	Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cance NCT00931606	Merck Sharp & Dohme LLC	Phase 2
Completed	Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy NCT00272662	Affymax	Phase 2
Completed	A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy NCT00144495	Chugai Pharmaceutical	Phase 3
Completed	A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy NCT00144482	Chugai Pharmaceutical	Phase 3